[New horizons in evidence-based haematological oncology: outcome and importance of the scientific activities of the Cochrane Haematologicial Malignancies Group (CHMG)].


Rising mortality and incidence rates for lymphoma and leukaemia in Germany are of great concern as they have socio-economic and health services implications. Evidence-based medicine (EBM) is one strategy to improve health outcomes of patients with haematological malignancies. The Cologne (Germany) based Cochrane Haematological Malignancies Group (CHMG) is… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics